ABSTRACT
Supravalvular aortic stenosis (SVAS) has been well described in Williams-Beuren Syndrome and non-syndromic elastin (ELN) mutations. Non-syndromic ELN mutations are inherited in an autosomal dominant pattern with incomplete penetrance and variable expressivity. ELN haploinsufficiency leads to progressive arteriopathy, typically affecting the aortic sinotubular junction. Multi-level pulmonary stenosis has also been reported and biventricular obstruction may portend a worse prognosis. Fetal presentation of ELN mutation with SVAS has not been previously reported in the literature. We present a case of fetal diagnosis of SVAS and multi-level pulmonary stenosis in a family with a known pathogenic ELN mutation (Exon 6, c.278del [p.Pro93Leufs*29]). On the fetus' initial fetal echo, there was only mild flow acceleration through the aortic outflow tract, however, she went on to develop progressive bilateral obstruction. In the early post-natal period, the child was clinically asymptomatic and showed similar mild SVAS and mild valvar and supravalvular pulmonary stenosis. Our case highlights the need for serial monitoring of fetuses with suspected or confirmed ELN arteriopathy.
Subject(s)
Aortic Stenosis, Supravalvular , Elastin , Mutation , Pulmonary Valve Stenosis , Adult , Female , Humans , Infant, Newborn , Pregnancy , Aortic Stenosis, Supravalvular/diagnostic imaging , Aortic Stenosis, Supravalvular/genetics , Elastin/genetics , Pulmonary Valve Stenosis/genetics , Pulmonary Valve Stenosis/diagnostic imaging , Ultrasonography, PrenatalABSTRACT
PURPOSE: The aim of this study was to identify the most accurate prenatal predictors of outcomes and need for fetal surgery for fetuses with high-risk lung masses and vascular tumors. METHODS: The records of all fetuses with high-risk lung mass (congenital cystic adenomatoid malformation-volume ratio > 1.6 or findings of hydrops) and vascular tumor evaluated between July 2001 and March 2011 were reviewed retrospectively. Hydrops was defined as accumulation of fluid in 2 or more compartments. RESULTS: Of fetuses with high-risk lung mass, hydrops was identified in 46% (11/24). Fetuses with hydrops and an abnormal echocardiogram (n = 8) demonstrated poor survival without fetal surgery (13%) compared with 100% survival in fetuses with hydrops and a normal echocardiogram (n = 3; P = .02). Of 21 fetuses with vascular tumor (11 sacrococcygeal and 8 cervical teratomas; 2 hemangioendotheliomas), hydrops was identified in 29% and an abnormal echocardiogram in 57%. All fetuses with hydrops had an abnormal echocardiogram and either died (n = 5) or required fetal surgery (n = 1). However, all fetuses with abnormal echocardiograms alone (n = 7) survived without fetal intervention. CONCLUSIONS: For fetuses with lung mass, an abnormal echocardiogram in the setting of hydrops is the best predictor of mortality and need for fetal surgery. For fetuses with vascular tumor, hydrops in the setting of high-output physiology best predicts demise and need for fetal surgery.
Subject(s)
Cystic Adenomatoid Malformation of Lung, Congenital/diagnosis , Cystic Adenomatoid Malformation of Lung, Congenital/surgery , Fetal Diseases/diagnosis , Fetal Diseases/surgery , Fetus/surgery , Hydrops Fetalis/diagnosis , Hydrops Fetalis/surgery , Prenatal Diagnosis , Vascular Neoplasms/diagnosis , Vascular Neoplasms/surgery , Cystic Adenomatoid Malformation of Lung, Congenital/complications , Female , Humans , Pregnancy , Retrospective Studies , Ultrasonography, Prenatal , Vascular Neoplasms/complicationsABSTRACT
This paper aims to help the reader understand the indications and the underlying physiologic concepts that relate to the findings obtained from a fetal cardiac evaluation. Techniques to obtain the basic fetal echocardiographic views and to identify gross cardiac abnormalities will also be discussed.
